Image source: Shutterstock
Highlights
- Adjusted EBITDA for FY25 is expected to surpass market expectations, supported by performance in the AES division.
- Revenue projections for FY25 remain in line with prior guidance.
- A detailed trading update will be provided in mid-June 2025.
Avingtrans PLC (LSE:AVG) operates in the design, manufacturing, and supply of critical components, modules, and systems primarily serving the energy, medical, and industrial sectors. The company provides associated services to support its product offerings across these industries.
The company has shared a trading update ahead of the financial year ending 31 May 2025 (FY25). According to the update, Avingtrans anticipates that adjusted EBITDA for FY25 will be above market expectations. This improvement is attributed mainly to the Advanced Engineering Systems (AES) division, which has delivered better-than-expected results during the year. The company expects revenue for the period to remain consistent with previous guidance and forecasts.
The AES division focuses on delivering complex engineering solutions, which appear to have contributed positively to the company’s overall earnings performance.
Avingtrans plans to release a more detailed trading update in mid-June 2025, providing further clarity on the company’s financial performance and operational developments. This forthcoming update will offer more comprehensive data and analysis for investors and stakeholders ahead of the final year-end reporting.
The company’s outlook will be clearer after the mid-June update, when it is expected to provide more detailed commentary on factors influencing its performance and any adjustments to full-year guidance or strategy.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.
Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.
Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.